Tags

RIS Export as RIS which can be imported into most citation managers
BibTeX Export as BibTeX which can be imported into most citation/bibliography managers
PDF Export formatted citations as PDF
RTF Export formatted citations as RTF which can be imported into most word processors
Delicious Export in format suitable for direct import into delicious.com. (Setup a permanent sync to delicious)
Formatted Text Export formatted citations as plain text

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

British journal of pharmacology, Vol. 169, No. 3. (June 2013), pp. 590-603, doi:10.1111/bph.12098  Key: citeulike:12888733

Formatted Citation

Show HTML

Likes (beta)

This copy of the article hasn’t been liked by anyone yet.

View FullText article

Abstract

Chronic lung diseases such as asthma, COPD and pulmonary fibrosis are characterized by abnormal extracellular matrix (ECM) turnover. TGF-β is a key mediator stimulating ECM production by recruiting and activating lung fibroblasts and initiating their differentiation process into more active myofibroblasts. Glycogen synthase kinase-3 (GSK-3) regulates various intracellular signalling pathways; its role in TGF-β₁-induced myofibroblast differentiation is currently largely unknown. To determine the contribution of GSK-3 signalling in TGF-β₁-induced myofibroblast differentiation. We used MRC5 human lung fibroblasts and primary pulmonary fibroblasts of individuals with and without COPD. Protein and mRNA expression were determined by immunoblotting and RT-PCR analysis respectively. Stimulation of MRC5 and primary human lung fibroblasts with TGF-β₁ resulted in time- and dose-dependent increases of α-sm-actin and fibronectin expression, indicative of myofibroblast differentiation. Pharmacological inhibition of GSK-3 by SB216763 dose-dependently attenuated TGF-β₁-induced expression of these myofibroblasts markers. Moreover, silencing of GSK-3 by siRNA or pharmacological inhibition by CT/CHIR99021 fully inhibited the TGF-β₁-induced expression of α-sm-actin and fibronectin. The effect of GSK-3 inhibition on α-sm-actin expression was similar in fibroblasts from individuals with and without COPD. Neither smad, NF-κB nor ERK1/2 were involved in the inhibitory actions of GSK-3 inhibition by SB126763 on myofibroblast differentiation. Rather, SB216763 increased the phosphorylation of CREB, which in its phosphorylated form acts as a functional antagonist of TGF-β/smad signalling. We demonstrate that GSK-3 signalling regulates TGF-β₁-induced myofibroblast differentiation by regulating CREB phosphorylation. GSK-3 may constitute a useful target for treatment of chronic lung diseases. © 2013 The Authors. British Journal of Pharmacology © 2013 The British Pharmacological Society.

guhjy’s tags for this article

Citations (CiTO)

No CiTO relationships defined

X There are no reviews yet

There are no reviews of this article

X Find related articles with these CiteULike tags

X Posting History

X Export records

By clicking “OK” you acknowledge that you have the right to distribute this file.

CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.